Cargando…

Soluble ST2 biomarker and reverse remodelling in patients with systolic heart failure

Detalles Bibliográficos
Autores principales: Yalta, Kenan, Zorkun, Cafer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902913/
https://www.ncbi.nlm.nih.gov/pubmed/29455780
http://dx.doi.org/10.1016/j.ihj.2017.11.003
_version_ 1783314841007554560
author Yalta, Kenan
Zorkun, Cafer
author_facet Yalta, Kenan
Zorkun, Cafer
author_sort Yalta, Kenan
collection PubMed
description
format Online
Article
Text
id pubmed-5902913
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-59029132019-01-01 Soluble ST2 biomarker and reverse remodelling in patients with systolic heart failure Yalta, Kenan Zorkun, Cafer Indian Heart J Correspondance Elsevier 2018 2017-11-07 /pmc/articles/PMC5902913/ /pubmed/29455780 http://dx.doi.org/10.1016/j.ihj.2017.11.003 Text en . http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Correspondance
Yalta, Kenan
Zorkun, Cafer
Soluble ST2 biomarker and reverse remodelling in patients with systolic heart failure
title Soluble ST2 biomarker and reverse remodelling in patients with systolic heart failure
title_full Soluble ST2 biomarker and reverse remodelling in patients with systolic heart failure
title_fullStr Soluble ST2 biomarker and reverse remodelling in patients with systolic heart failure
title_full_unstemmed Soluble ST2 biomarker and reverse remodelling in patients with systolic heart failure
title_short Soluble ST2 biomarker and reverse remodelling in patients with systolic heart failure
title_sort soluble st2 biomarker and reverse remodelling in patients with systolic heart failure
topic Correspondance
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902913/
https://www.ncbi.nlm.nih.gov/pubmed/29455780
http://dx.doi.org/10.1016/j.ihj.2017.11.003
work_keys_str_mv AT yaltakenan solublest2biomarkerandreverseremodellinginpatientswithsystolicheartfailure
AT zorkuncafer solublest2biomarkerandreverseremodellinginpatientswithsystolicheartfailure